Literature DB >> 16043287

The role of Na(V)1.8 sodium channel in the maintenance of chronic inflammatory hypernociception.

Cristiane Flora Villarreal1, Daniela Sachs, Fernando de Queiroz Cunha, Carlos Amílcar Parada, Sérgio Henrique Ferreira.   

Abstract

We previously described an animal model of persistent inflammatory sensitization of nociceptors. In this model the hypernociception persists for more than 30 days after the cessation of 2 weeks of daily intraplantar treatment with prostaglandin E(2) (PGE(2)). The tetrodotoxin-resistant (TTX-R) voltage-gated sodium channel Na(V)1.8 is considered a characteristic of primary afferent nociceptive C fibers and plays an important role in acute hypernociception. In the present study, the relevance of the Na(V)1.8 channel was investigated in this model of persistent mechanical hypernociception in rats. In the PGE(2)-induced persistent hypernociception, but not in the single injection-induced acute hypernociception, the mRNA expression (RT-PCR) of Na(V)1.8 in dorsal root ganglia (DRG) was up-regulated. A similar increase of Na(V)1.8 mRNA was observed when DbcAMP was used to induce persistent hypernociception. Four daily intrathecal administrations of oligodeoxynucleotides (ODN) antisense against Na(V)1.8 decreased the mRNA encoding Na(V)1.8 in DRG. The intrathecal administration of ODN antisense prevented the PGE(2)-induced acute hypernociception and significantly reduced ongoing PGE(2)-induced persistent hypernociception. A parallel restoration of the persistent hypernociception and up-regulation of Na(V)1.8 mRNA was observed after the cessation of ODN antisense treatment. These results suggest the participation of Na(V)1.8 channels in the development and maintenance of chronic inflammatory hyperalgesia, and confirm their involvement in the acute inflammatory hypernociception.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16043287     DOI: 10.1016/j.neulet.2005.04.060

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  20 in total

1.  A novel substituted aminoquinoline selectively targets voltage-sensitive sodium channel isoforms and NMDA receptor subtypes and alleviates chronic inflammatory and neuropathic pain.

Authors:  Boris Tabakoff; Wenhua Ren; Lauren Vanderlinden; Lawrence D Snell; Christopher J Matheson; Ze-Jun Wang; Rock Levinson; C Thetford Smothers; John J Woodward; Yumiko Honse; David Lovinger; Anthony M Rush; William A Sather; Daniel L Gustafson; Paula L Hoffman
Journal:  Eur J Pharmacol       Date:  2016-05-05       Impact factor: 4.432

2.  Antinociceptive action of carbamazepine on thermal hypersensitive pain at spinal level in a rat model of adjuvant-induced chronic inflammation.

Authors:  Tatsushige Iwamoto; Yoshihiro Takasugi; Hideaki Higashino; Hiroyuki Ito; Yoshihisa Koga; Shinichi Nakao
Journal:  J Anesth       Date:  2010-11-27       Impact factor: 2.078

3.  PKCepsilon-dependent potentiation of TTX-resistant Nav1.8 current by neurokinin-1 receptor activation in rat dorsal root ganglion neurons.

Authors:  Chun-Lei Cang; Hua Zhang; Yu-Qiu Zhang; Zhi-Qi Zhao
Journal:  Mol Pain       Date:  2009-06-30       Impact factor: 3.395

4.  Bilateral downregulation of Nav1.8 in dorsal root ganglia of rats with bone cancer pain induced by inoculation with Walker 256 breast tumor cells.

Authors:  Xue-Rong Miao; Xiao-Fei Gao; Jing-Xiang Wu; Zhi-Jie Lu; Zhang-Xiang Huang; Xiao-Qing Li; Cheng He; Wei-Feng Yu
Journal:  BMC Cancer       Date:  2010-05-20       Impact factor: 4.430

5.  Blockade of Nav1.8 currents in nociceptive trigeminal neurons contributes to anti-trigeminovascular nociceptive effect of amitriptyline.

Authors:  Jingyao Liang; Xiaoyan Liu; Meiyan Pan; Wei Dai; Zhao Dong; Xiaolin Wang; Ruozhuo Liu; Jianquan Zheng; Shengyuan Yu
Journal:  Neuromolecular Med       Date:  2013-11-30       Impact factor: 3.843

6.  [Topical ambroxol for the treatment of neuropathic pain: A first clinical observation. German version].

Authors:  K-U Kern; T Weiser
Journal:  Schmerz       Date:  2015-12       Impact factor: 1.107

7.  Persistent pain after spinal cord injury is maintained by primary afferent activity.

Authors:  Qing Yang; Zizhen Wu; Julia K Hadden; Max A Odem; Yan Zuo; Robyn J Crook; Jeffrey A Frost; Edgar T Walters
Journal:  J Neurosci       Date:  2014-08-06       Impact factor: 6.167

8.  A novel selective and orally bioavailable Nav 1.8 channel blocker, PF-01247324, attenuates nociception and sensory neuron excitability.

Authors:  Claire Elizabeth Payne; Adam R Brown; Jonathon W Theile; Alexandre J C Loucif; Aristos J Alexandrou; Mathew D Fuller; John H Mahoney; Brett M Antonio; Aaron C Gerlach; David M Printzenhoff; Rebecca L Prime; Gillian Stockbridge; Anthony J Kirkup; Anthony W Bannon; Steve England; Mark L Chapman; Sharan Bagal; Rosemarie Roeloffs; Uma Anand; Praveen Anand; Peter J Bungay; Mark Kemp; Richard P Butt; Edward B Stevens
Journal:  Br J Pharmacol       Date:  2015-04-10       Impact factor: 8.739

9.  Nociceptors as chronic drivers of pain and hyperreflexia after spinal cord injury: an adaptive-maladaptive hyperfunctional state hypothesis.

Authors:  Edgar T Walters
Journal:  Front Physiol       Date:  2012-08-02       Impact factor: 4.566

10.  Antisense-mediated knockdown of Na(V)1.8, but not Na(V)1.9, generates inhibitory effects on complete Freund's adjuvant-induced inflammatory pain in rat.

Authors:  Yao-Qing Yu; Feng Zhao; Su-Min Guan; Jun Chen
Journal:  PLoS One       Date:  2011-05-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.